Respiratory disorders have an impact on health globally. Respiratory diseases comprise the fifth of the thirty most common causes of death. COPD is third, lower respiratory tract infection is fourth, tracheal, bronchial, and lung cancer is sixth, tuberculosis (TB) is 12th, and asthma is 28th. Though chronic respiratory diseases are not treatable, different treatments can help control their symptoms, increase the quality of a patient's life, and prevent adverse outcomes (including exacerbations) associated with substantial morbidity, disability, increased healthcare use, and risk of death.
Intubation plays a significant role in treating any chronic respiratory illness. Endotracheal intubation helps in controlled airway flow in patients who need invasive ventilation. To reduce the burden on patients, the healthcare system, and the government, manufacturers have developed antimicrobial coatings that traditionally include silver or any other drug with antimicrobial properties and can prevent biofilm formation on ETs. These factors have contributed to the growth of the endotracheal tube market worldwide.
With the rising prevalence of various acute and chronic diseases, the number of surgeries performed is increasing rapidly. According to WHO, around 234 million major surgical procedures are performed every year globally. Factors such as growth in the geriatric population, increasing options for minimally invasive surgery, and technological advances for surgical procedures contribute to the growing number of surgeries. In addition, orthopedic, laparoscopic, bariatric, gynecological, and gastrointestinal surgeries largely accounted for the rise in the volume of surgical procedures performed globally, driving the market growth.
Lack of experience or skill in performing ETI can severely impact the patient's life. Improper treatment can affect the patient's condition, increase the recovery time, and fuel-associated expenses. In emergencies, diagnosing and inefficiently treating severe injuries can cause dysfunction and deformities in the injured area. Such circumstances hinder the usage of endotracheal tubes. In addition, endotracheal intubation is a routine procedure performed by anesthesiologists. Complications following this procedure are not uncommon and include sore throat, hoarseness of voice, dysphagia, and others. The movement of the tube and cuff in the trachea increases the risk of postoperative throat complaints, thereby restricting market growth.
Video laryngoscopy may play a relevant role as compared to conventional intubation techniques. Video laryngoscopy (VL)/video laryngoscope improves the glottis view and allows supervision by an expert during the intubation process. VL is proposed to improve airway management and reduce the incidence of difficult intubation. Video laryngoscopes have rapidly become routine devices for airway management in many situations, especially in an ICU than operating rooms. In addition, video laryngoscopy in ICUs for endotracheal intubation (ETI) should increase the first-pass success rate, decrease the duration required for ETI, and ensure constant supervision and guidance on airway expertise to improve patient outcomes.
Furthermore, VL is ideally recommended in patients infected with COVID-19 to increase the distance between the operator's face and the patient's face to minimize the risk of contamination. In addition, VL offers a better view of the glottic entrance and can facilitate a quick-pass first-attempt tracheal instrumentation. A VL should be available in all ICUs as a powerful tool for rescuing difficult intubation or failed first-pass laryngoscopy in expert hands. This can extend the usage of ETs and increase the demand for ETs with antimicrobial coatings, thereby contributing to market growth. Such factors create opportunities for the market's growth.
The global endotracheal tubes market is bifurcated into intubation, product type, application, material type, and end-user.
Based on intubation, the global endotracheal tubes market is divided into oral, nasal, and others.
The oral segment accounts for the largest market share and is anticipated to grow at a CAGR of 4.22% over the forecast period. Oral ETs are used for oral endotracheal intubation or orotracheal intubation. This process is an advanced airway procedure involving the insertion of an oral ET under laryngoscopy into the trachea. One of the significant advantages of orotracheal intubation is that it can be easily and quickly performed. A larger tube facilitates suction and procedures such as bronchoscopy and less kinking of the ET. Orotracheal intubation is preferred to nasotracheal intubation and is done via direct or video laryngoscopy.
Based on product type, the global endotracheal tubes market is divided into uncuffed and cuffed.
The uncuffed segment is the most significant contributor to the market and is estimated to exhibit a CAGR of 3.89% over the forecast period. Traditionally, uncuffed endotracheal tubes have been used for artificial ventilation in infants and children. It is recommended for children up to eight years old. Frequently cited reasons for this practice include adding a cuff that necessitates a smaller tube, which increases airway resistance and the work of breathing. Cuffs increase the risk of airway mucosa injury. They are unnecessary because appropriately sized uncuffed tubes seal well at the cricoid ring, where the lumen is the narrowest in children.
Based on application, the global endotracheal tubes market is bifurcated into anesthesia and critical care, emergency care, and others.
The anesthesia and critical care segment owns the highest market share and is predicted to grow at a CAGR of 3.72% over the forecast period. Endotracheal intubation is performed during general anesthesia before surgeries or in critically ill patients to assist breathing. Modern endotracheal anesthesia is a technique in which the administration of an anesthetic may be facilitated. This technique can benefit from an artificial extension of the tracheobronchial tree utilizing a tube through which the patient's respiratory exchange occurs. Advancements in endotracheal tubes have closely followed advances in anesthesia and surgery.
Based on material type, the global endotracheal tubes market is divided into PVC, silicone, and others.
The PVC segment accounts for the highest market share and is estimated to grow at a CAGR of 4.04% over the forecast period. The most commonly used ET material is PVC, a transparent plastic that allows the visualization of exhalation condensation secretions and other foreign materials within the tube. It is a semi-rigid material at room temperature but relatively more pliable as it warms following placement in the trachea, which permits easy manipulation of the tube tip during intubation while reducing the risk of mucosal ischemia following placement.
Based on end-user, the global endotracheal tubes market is divided into hospitals, specialty clinics, ambulatory surgical centers, and others.
The hospital segment is the largest contributor to the market and is anticipated to exhibit a CAGR of 3.56% over the forecast period. Patients' conditions can deteriorate rapidly in a hospital environment for various reasons. Maintaining a patient's breathing is the main priority in any emergency, although achieving airway control can be difficult. Major operations such as heart surgeries, knee and hip replacements, and surgical procedures to treat cancer require intubation while the surgery is performed. With the growing number of surgical procedures in hospitals, the need to maintain airway control, especially for patients, has increased the utilization of airway management devices. In particular, the number of patients requiring intubation and mechanical ventilation has increased in hospital settings. Sometimes, newborn infants may require endotracheal intubation while undergoing general anesthesia during surgery.
Based on region, the global endotracheal tubes market is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America is the most significant global endotracheal tubes market and is expected to grow at a CAGR of 3.08% over the forecast period. The market in this region is contributed by the increase in surgical procedures owing to the rise in chronic diseases, including respiratory diseases, cardiovascular diseases, lung cancer, and other lung injuries. According to the Centers for Disease Control and Prevention (CDC) 2018, one in 13 people have asthma, and more than 25 million Americans have asthma, and in 2017, one in 12 children had asthma. In addition, it is estimated that 16 million adults have COPD. Owing to the surge in population affected by such conditions, the use of ETs has increased significantly as mechanical ventilation is essential, thereby contributing to market growth.
Furthermore, growth in the aging population and a high surge in VAP patients significantly contribute to the market's growth. Factors such as advanced healthcare infrastructure and the development of various coated ETs are increasing awareness among end-users in promoting the demand for endotracheal tubes. Further, the outbreak of the COVID-19 pandemic has drastically increased the usage of ETs in healthcare settings since many patients have been suffering from breathing difficulties and respiratory distress.
Europe is anticipated to exhibit a CAGR of 4.33% over the forecast period. Chronic disease-related aging and its prevalence have dramatically increased over time in the European region. Further, due to risk factors such as smoking, pollution, and other underlying diseases, there has been an increasing prevalence of chronic respiratory diseases among adults and the elderly. In Europe, respiratory problems remain an essential health problem across countries. Also, almost 10 million people aged less than 45 have asthma. In the European Union (EU), 8.2% of adults and 9.4% of children have asthma. It is also estimated that as many as 66 million people in the European region may live with COPD. The COPD mortality rate for men and women in Europe, age-standardized to the European Standard Population, is about 18 per 100,000 inhabitants per year. Further, a highly advanced healthcare system and an increased number of vendors offering a variety of ETs are boosting the market growth in this region.
Asia-Pacific is predicted to witness the fastest growth rate compared to other regions in the global endotracheal tubes market during the forecast period. The region is seeing growth in the elderly population and people associated with respiratory disorders such as COPD and Asthma. Further, the rise in hospital admissions, especially in NICU (Neonatal Intensive Care Unit)/PICU (Pediatric Intensive Care Unit), increase in cardiovascular and lung injuries, growing demand for coated ETs, and advances in the healthcare system are enhancing the growth of the global endotracheal tubes market in the APAC region.
The prevalence of various respiratory diseases drives the demand for ETs in Latin America. For instance, the prevalence of COPD is ranged between 6.2% to 19.6% in individuals aged above 40, with substantial rates of underdiagnosis (up to 89%). The death due to COPD per 100,000 in Argentina is higher than in Brazil and Mexico. It is also home to around 40 million asthmatics. The prevalence of asthma patients in Latin America is about 6% in adults, which is increasing. Such respiratory diseases will increase the number of patients needing airway management services that involve intubation.
In the Middle East and Africa region, there has been growth in surgeries performed, particularly in countries such as the UAE, Israel, Saudi Arabia, and South Africa. Cosmetic, bariatric, cardiovascular, and orthopedic surgeries are commonly performed in these countries. With the growth in the medical tourism industry, these countries are gaining more popularity due to their cost-effective surgical procedures across the region. This, in turn, contributes to the rise in the use of ETs.
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends|